Search: onr:"swepub:oai:DiVA.org:oru-24625" > Circadian disruptio...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04281naa a2200385 4500 | |
001 | oai:DiVA.org:oru-24625 | |
003 | SwePub | |
008 | 120821s2012 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-246252 URI |
024 | 7 | a https://doi.org/10.1158/1055-9965.EPI-12-01162 DOI |
040 | a (SwePub)oru | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Sigurdardottir, Lara G.u Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; The Icelandic Cancer Society, Reykjavik, Iceland4 aut |
245 | 1 0 | a Circadian disruption, sleep loss, and prostate cancer risk :b a systematic review of epidemiologic studies |
264 | 1 | a Philadelphia, USA :b American Association for Cancer Research,c 2012 |
338 | a print2 rdacarrier | |
500 | a Funding Agency:Icelandic Research Fund | |
520 | a Disruption of the circadian system has been hypothesized to increase cancer risk, either because of direct disruption of the molecular machinery generating circadian rhythms or because of disruption of parameters controlled by the clock such as melatonin levels or sleep duration. This hypothesis has been studied in hormone-dependent cancers among women, but data are sparse about potential effects of circadian disruption on the risk of prostate cancer. This review systematically examines available data evaluating the effects of light at night, sleep patterns, and night shift work on prostate cancer risk. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Epidemiologi | |
653 | a Epidemiology | |
700 | 1 | a Valdimarsdottir, Unnur A.u Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Clinical Epidemiology Unit, Örebro University Hospital, Örebro, Sweden; Örebro University, Örebro, Sweden; Department of Epidemiology, Harvard School of Public Health, Boston MA, USA4 aut |
700 | 1 | a Fall, Katja,d 1971-u Örebro universitet,Institutionen för hälsovetenskap och medicin,Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Clinical Epidemiology Unit, Örebro University Hospital, Örebro, Sweden; Department of Epidemiology, Harvard School of Public Health, Boston MA, USA4 aut0 (Swepub:oru)kafl |
700 | 1 | a Rider, Jennifer R.u Department of Epidemiology, Harvard School of Public Health, Boston MA, USA; Channing Laboratory, Harvard Medical School, Boston MA, USA4 aut |
700 | 1 | a Lockley, Steven W.u Division of Sleep Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston MA, USA; Division of Sleep Medicine, Harvard Medical School, Boston MA, USA4 aut |
700 | 1 | a Schernhammer, Eva S.u Department of Epidemiology, Harvard School of Public Health, Boston MA, USA; Channing Laboratory, Harvard Medical School, Boston MA, USA4 aut |
700 | 1 | a Mucci, Lorelei A.u Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Department of Epidemiology, Harvard School of Public Health, Boston MA, USA; Channing Laboratory, Harvard Medical School, Boston MA, USA4 aut |
710 | 2 | a Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; The Icelandic Cancer Society, Reykjavik, Icelandb Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Clinical Epidemiology Unit, Örebro University Hospital, Örebro, Sweden; Örebro University, Örebro, Sweden; Department of Epidemiology, Harvard School of Public Health, Boston MA, USA4 org |
773 | 0 | t Cancer Epidemiology, Biomarkers and Preventiond Philadelphia, USA : American Association for Cancer Researchg 21:7, s. 1002-1011q 21:7<1002-1011x 1055-9965x 1538-7755 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-24625 |
856 | 4 8 | u https://doi.org/10.1158/1055-9965.EPI-12-0116 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.